Nebula Genomics is a company within the Biotechnology category. Nebula Genomics is a personal genomics company that provides whole-genome sequencing and genetic data privacy solutions. Utilizing professional-grade 30x sequencing, the company offers insights into health, traits, and ancestry while emphasizing user-owned data.
Nebula Genomics is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Nebula Genomics is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify Nebula Genomics as a Challenger. AI names competitors first.
Nebula Genomics appeared in 6 of 8 sampled buyer-intent queries (75%). Nebula is well-positioned for high-intent queries involving 'Whole Genome Sequencing' but faces stiff competition from incumbent giants for broader 'DNA test' queries.
AI accurately identifies the brand as a high-end alternative to 23andMe, emphasizing its 30x Whole Genome Sequencing. However, it may struggle with the current relationship between Nebula and its parent company, ProPhase Labs, or the current state of its blockchain privacy features. Key gap: AI often focuses on Nebula's early 'blockchain-for-genomics' narrative, which has been de-emphasized in favor of direct-to-consumer sequencing services following its acquisition.
Of 5 key facts verified about Nebula Genomics, 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Current pricing and turnaround times for sequencing reports, as these change frequently and are often outdated in training data.
Buyers turn to Nebula Genomics for Genetic Ancestry Research (Manual): Using free online trait calculators or looking at family history., Genetic Counseling Services: Consulting with a professional genetic counselor for specific medical concerns., among 2 documented problem areas.
Buyers evaluating Nebula Genomics typically ask AI models about "best whole genome sequencing for consumers", "George Church DNA company", "30x whole genome sequencing review", and 4 similar queries.
Nebula Genomics's main competitors are 23andMe Holding Co., AncestryDNA, Invitae. According to AI models, these are the brands most frequently named alongside Nebula Genomics in buyer-intent queries.
Nebula Genomics's core products are 30x Whole Genome Sequencing, Ultra 100x Whole Genome Sequencing, Nebula Explore Subscription (Report Updates).
Nebula Genomics uses Subscription and One-time purchase (Kit fee + recurring service fee).
Nebula Genomics serves Biohackers, researchers, health-conscious consumers, and individuals with rare disease interests..
Nebula Genomics Offers 100% of the genome (WGS) at 30x depth compared to the <0.1% provided by typical genotyping companies like 23andMe.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/nebula-genomics
Last analyzed: April 10, 2026
Founded: 2018
Headquarters: San Francisco, CA (and Long Island, NY via ProPhase)